1. Introduction {#sec0001}
===============

Metabolic syndrome (MetS), a cluster of metabolic risk factors leading to the development of cardiovascular disease and diabetes, is a rapidly increasing global threat, affecting 20%--30% of adults worldwide.[@bib0001] It is expected to increase further, given aging populations in many countries and changes in lifestyle habits related to westernization.[@bib0001], [@bib0002], [@bib0003]

Physical activity (PA) is an important modifiable factor for MetS that is available to people around the world.[@bib0004] Studies in various countries have shown the associations between MetS and PA in their population cohorts.[@bib0005], [@bib0006], [@bib0007], [@bib0008] However, there is variability across populations in regard to how much PA contributes to MetS prevalence.[@bib0005], [@bib0006], [@bib0007], [@bib0008] Without consistency in the measurement methods for PA, it is currently unknown whether these perceived differences in risk contribution across different cultures or countries are real or are artifacts of differential bias caused by using different methods of PA measurement.[@bib0009] This is unfortunate because examining the associations between PA levels and MetS across cohorts with different lifestyle habits and different rates of MetS has the potential to better illuminate the mechanisms underlying the relationship between PA and MetS.

Most previous studies have used recall questionnaires to assess self-reported PA levels.[@bib0005], [@bib0006], [@bib0007], [@bib0008] However, studies with cohorts from more than 1 country are rare and there are many different types of PA questionnaires, resulting in the use of different questionnaires across studies. In general, questionnaires are best for measuring domain-specific planned activities (e.g., leisure, occupational, and commuting) that are of moderate-to-vigorous intensity because people are able to recall these activities better.[@bib0010] Not all questionnaires capture all domains; nevertheless, most studies present their findings as being generically based on "physical activity" regardless of the components of PA that are represented. Even in cases where the same questionnaire is used and translated into different languages, there can be problems related to interpretation bias, cultural sensitivity for reporting certain activities, or missing information on activities that are important in one culture versus another.[@bib0011]^,^[@bib0012] These issues can make it difficult to interpret differences in the associations between PA and MetS in cohorts from different countries because perceived differences in risk association could simply result from differences in how PA is measured and which components of PA are reported across questionnaires.

Some recent studies using objective measures such as pedometers or accelerometers have greater potential for comparability across studies because pedometers and accelerometers are not subject to the same types of reporting bias as recall questionnaires and allow for a higher degree of standardization of measurement across populations when the same instrument, protocol, and processing methods are utilized.[@bib0013] These monitors primarily capture ambulatory movement. Although they may misreport (or not report) non-ambulatory activities, such as biking or swimming, the output from these devices is often used as a proxy for total movement, which is something that cannot be validly assessed by questionnaire.[@bib0010]^,^[@bib0013] However, because pedometers and accelerometers cannot capture domain-specific PA, such as leisure PA (which is typically the target of PA intervention programs), it has been suggested that the most effective method of measuring PA is with the combination of accelerometers or pedometers and a questionnaire. Thus, to provide the best assessment of the relationship between PA and MetS across countries, both a questionnaire that reports domain-specific PA and can be modified to suit all included populations and an objective measure of total movement are needed.[@bib0014]

There have been only a few studies comparing PA across countries, and all of them used different questionnaire-based methods for the assessment of PA without using pedometers or accelerometers.[@bib0015], [@bib0016], [@bib0017], [@bib0018] This is unfortunate because examining the associations between PA levels and MetS across cultures with different lifestyle habits and different rates of MetS has the potential to better illuminate the mechanisms underlying the relationship between PA and MetS and to provide better international PA guidelines geared toward lowering the prevalence of MetS and the development of lifestyle-induced cardiovascular disease and diabetes.

The United States has one of the highest rates of MetS, affecting about 30% of adults,[@bib0019] whereas only 5%--10% of Japanese adults have MetS,[@bib0020] which is one of the lowest rates in the world. Additionally, 1 study based on self-reported PA suggested that Americans may perform PA at more vigorous levels while Japanese engage in more moderate-intensity walking.[@bib0018] However, no previous studies have uniformly collected and directly compared PA levels in the United States and Japan using objective methods, and no previous studies have compared the association of PA and MetS across these 2 countries. Therefore, examining differences in risk contribution of both total PA and domain-specific PA from standardized and validated instruments across cohorts in Japan and the United States has the potential to contribute new knowledge on the importance of PA as a modifiable risk factor for MetS prevalence in both countries. The results of such a study may also help to inform future international efforts on how to measure the contribution of PA to the development of MetS and individual MetS components.

Using data from the electron beam computed tomography and Risk Factor Assessment among Japanese and U.S. Men in the Post-World War II Birth Cohort (ERA-JUMP) Study, we compared characteristics of PA across the American and Japanese cohorts. We also examined the associations between both subjectively and objectively measured PA levels and MetS in each cohort using a single questionnaire and standardized collection/evaluation tools for pedometer step counts across cohorts.

2. Materials and methods {#sec0002}
========================

2.1. Study population {#sec0003}
---------------------

Details of the ERA-JUMP Study have been described previously.[@bib0021]^,^[@bib0022] Briefly, the ERA-JUMP Study was established to investigate differences in subclinical atherosclerosis among men aged 40--49 years at baseline (2002--2006) in different populations. Study participants were population-based samples of American men from Allegheny County, Pennsylvania, USA, and Japanese men from Kusatsu, Shiga, Japan, all of whom completed a follow-up examination between 2008 and 2013 (when PA assessments were completed for both the American and Japanese sub-cohorts in the ERA-JUMP Study). Both the American (*n* = 417) and Japanese (*n* = 313) cohorts were randomly selected from local registries. All participants were without clinical cardiovascular disease, type 1 diabetes, or other severe disease. The current study utilized cross-sectional data from the follow-up visit for the main ERA-JUMP Study because that is when PA data from questionnaires and pedometers were collected from both cohorts.

We excluded 172 participants who did not have a follow-up visit (114 American men and 58 Japanese men) and 48 participants who did not have pedometer and/or modifiable activity questionnaire (MAQ) data (38 American men and 10 Japanese men). Our final sample consisted of 510 participants: 265 American (222 Caucasian and 43 African American) men and 245 Japanese men. Compared to our final sample, the 172 participants who were originally excluded because they did not have a follow-up visit had a significantly higher body mass index (BMI) (American: 26.1 ± 4.6 *vs.* Japanese: 27.0 ± 5.7, *p* = 0.048), although no differences existed for age, prevalence of MetS and its components, or percentage with self-reported leisure PA of 1 h/week or more (data not shown). The present study was approved by the Institutional Review Boards of the University of Pittsburgh and Shiga University of Medical Science and written informed consent was collected from all participants.

2.2. PA assessment {#sec0004}
------------------

To capture both total and domain-specific PA (leisure and occupational), both subjective and objective measurement tools were used. The MAQ, a previously validated interviewer-administered recall questionnaire, was used to assess both leisure and occupational activities that mostly were of moderate-to-vigorous intensity.[@bib0023]^,^[@bib0024] The MAQ version used in this study was specifically modified for use across these 2 country-specific cohorts and has previously been modified and translated for use in several different countries. Prior to administration, the MAQ was piloted at both study sites to ensure the comprehensive inclusion of activities that were culturally relevant for both sites.[@bib0025] All staff administering the MAQ were trained and certified prior to data collection. Participants were asked to report primarily moderate- to vigorous-intensity leisure and occupational activity that occurred during the 6 months immediately before their clinic visit. PA levels were then calculated by the staff as the product of the duration and frequency of each activity (in h/week), weighted by the estimate of the metabolic task equivalent (MET)[@bib0026] of that activity (from the Compendium of Physical Activities),[@bib0027] and summed for all activities performed. Data were expressed as MET hours per week (MET-h/week) averaged over the 6-month period.

Objectively measured PA data were collected via the Yamax Digiwalker SW-200 pedometer (Yamasa Tokei Keiki Corporation, Tokyo, Japan). The digiwalker SW-200 is a spring-levered pedometer that records steps taken. Pedometers are best at assessing ambulatory activity levels and collect both moderate- to vigorous-intensity and light-intensity movement. The validity and reliability of this device in counting steps have been shown in various laboratory and field settings.[@bib0028]^,^[@bib0029]

Participants were asked to wear the pedometer during all waking hours for 7 consecutive days and to only remove the monitor for sleeping, showering, and other water activities. Participants recorded the number of steps taken in an activity diary at the end of each day. They were also asked to report monitor time on/off. Monitors and diaries were then returned to the clinic in a postage-paid envelope. Per previously validated protocol, only participants with 3 or more days of data were included in the study.[@bib0030] If there was a question regarding compliance with monitor wear instructions, diary on/off times were used to confirm compliance. The data were then summed as average step counts per day (the sum of total step counts recorded divided by the number of reported days). Pedometer steps were further categorized to correspond with previously reported cut points for low (\<5000 steps/day), moderate (5000 to \<10,000 steps/day), and high (≥10,000 steps/day) activity.[@bib0031]

2.3. Other measures {#sec0005}
-------------------

Body weight and height were measured with the participants wearing light clothing but without shoes. BMI was calculated as weight (in kilograms) divided by height squared (in meters squared). Waist circumference (WC) was measured with a tape measure at the level of the umbilicus while the participants were standing and at the end of exhalation. Blood pressure (BP) was measured in the right arm of the seated participants after emptying their bladder and sitting quietly for 5 min, using an automated sphygmomanometer (BP-8800; Colin Medical Technology, Komaki, Japan). The average of 2 measurements was used in the analyses. Smoking (never, former, or current), alcohol consumption (≥2 days/week), and medication use (anti-hypertensive, anti-diabetic, and lipid lowering) was assessed via questionnaire. Venipuncture was performed early in the clinic visit after a 12-h fast. Serum and plasma samples were stored at --80°C and shipped to the University of Pittsburgh. Serum/plasma samples were assayed for glucose and lipids as described previously.[@bib0021] For the comparison of BP, blood glucose, and lipid levels, those on medications were excluded. MetS and individual components were defined according to the updated National Cholesterol Education Program Adult Treatment Panel-III criteria, which take into account medications for the different components.[@bib0032] Specifically, MetS was defined as 3 or more of 5 components: elevated WC (≥102 cm in American men and ≥90 cm in Japanese men), elevated BP (systolic BP ≥130 mmHg or diastolic BP ≥85 mmHg), elevated triglycerides (≥150 mg/dL), reduced high-density lipoprotein (HDL) cholesterol (\<40 mg/dL), and elevated fasting glucose (≥100 mg/dL). Per protocol, individuals on BP, blood glucose, and/or lipid-lowering medications were defined as having the treated MetS components. However, a sensitivity analysis was also done in which individuals on medications were not included. Obesity was defined as a BMI of 25 kg/m^2^or greater for Japanese men and BMI of 30 kg/m^2^or greater for American men.[@bib0033]

2.4. Statistical analysis {#sec0006}
-------------------------

Means, medians, and frequencies of characteristics between the 2 populations were compared using the *t* test, Wilcoxon rank-sum test, and *χ*^2^ test, as appropriate. Specifically, fasting glucose and triglycerides were compared using the Wilcoxon rank-sum test. American men were further classified by race (Caucasian and African American) to describe characteristics of participants. Odds ratios (ORs) for having MetS, MetS components, and obesity per 1000 pedometer steps and separately, per 1 MET-h/week from the MAQ (equivalent to 20 min of moderate-intensity PA at 3.0 METs) were assessed using logistic regression analysis adjusted for important covariates, including age, smoking history, and alcohol consumption. Statistical significance was determined by a *p* value of less than 0.05. All statistical analyses were performed using SAS software Version 9.4 (SAS Institutes Inc., Cary, NC, USA).

3. Results {#sec0007}
==========

3.1. Characteristics of participants {#sec0008}
------------------------------------

At the follow-up visit, American participants (*n* = 265) appeared to be slightly younger than Japanese participants (*n* = 245) on average (49.8 ± 2.9 years *vs.* 51.2 ± 2.8 years, *p* \< 0.0001) ([Table 1](#tbl0001){ref-type="table"}). American participants also had a higher BMI than their Japanese counterparts (29.2 ± 4.9 kg/m^2^ *vs.* 23.8 ± 3.2 kg/m^2^, *p* \< 0.0001), although no difference in obesity was observed after using ethnic-group-specific BMI cut points (32% *vs.* 31%, *p* = 0.70). A significantly higher percentage of Japanese men reported past or current smoking and alcohol consumption ≥2 times/week (both *p* \< 0.0001) ([Table 1](#tbl0001){ref-type="table"}).Table 1Characteristics of participants by site (men aged 44--56 years, 2008--2013).Table 1Pittsburgh (*n* = 265)Kusatsu (*n* = 245)*p***Age (year)**49.8 ± 2.951.2 ± 2.8\<0.0001**Education (year)**16.8 ± 2.814.3 ± 2.1\<0.0001**Smoking status**\<0.0001Never194 (73)46 (19)Past49 (18)103 (42)Current22 (8)96 (39)**Alcohol (≥2 times/week)**116 (44)164 (67)\<0.0001**Comorbidity**Waist circumference (cm)101.8 ± 13.185.7 ± 8.7\<0.0001BMI (kg/m^2^)29.2 ± 4.923.8 ± 3.2\<0.0001Obesity^a^85 (32)75 (31)0.70Systolic blood pressure (mmHg)^b^126.2 ± 13.3126.9 ± 16.00.59Diastolic blood pressure (mmHg)^b^76.5 ± 8.880.5 ± 11.5\<0.0001Antihypertensive mediations51 (19)39 (16)0.34Hypoglycemic medications12 (5)12 (5)0.84Lipid-lowering medications54 (21)17 (7)\<0.0001Total cholesterol (mg/dL)^b^217.9 ± 38.0211.4 ± 33.90.06HDL cholesterol (mg/dL)^b^50.0 ± 12.356.5 ± 16.7\<0.0001LDL cholesterol (mg/dL)^b^137.9 ± 33.6126.6 ± 32.4\<0.001Triglycerides (mg/dL)^b^148.9 ± 85.0144.9 ± 110.10.34Fasting glucose (mg/dL)^b^107.0 ± 16.1101.8 ± 11.3\<0.0001**Metabolic syndrome^c^102 (38)63 (26)0.002**High waist circumference^d^114 (43)68 (28)\<0.001High blood pressure^e^103 (39)108 (44)0.23High glucose^f^193 (73)134 (55)\<0.0001High triglycerides^g^101 (38)89 (36)0.68Low HDL cholesterol^h^57 (22)21 (9)\<0.0001[^1][^2][^3]

Overall, American participants were significantly more likely to have MetS (38% *vs.* 26%, *p* = 0.002). Differences in hypoglycemic and antihypertension medication use were small and non-significant between the Japanese and American cohorts (*p* \> 0.05). However, the use of lipid-lowering medications was 3 times higher in the American men when compared to the Japanese men (21% *vs.* 7%, *p* \< 0.0001). Among other MetS criteria, American participants were also significantly more likely to have high WC, high blood glucose, and low HDL cholesterol, although there was no significant difference in the proportion in each cohort with high BP and high triglycerides (based on *p* \< 0.05). When examining only those without medication, American participants had significantly lower diastolic BP, HDL cholesterol, and higher blood glucose levels ([Table 1](#tbl0001){ref-type="table"}).

3.2. PA levels {#sec0009}
--------------

American participants had significantly lower mean (±SD) pedometer steps per day compared to Japanese participants (7878 ± 3399 steps/day *vs.* 9055 ± 3797 steps/day, *p* \< 0.001). There were significantly fewer American participants with 10,000 or more steps/day (21% *vs.* 35%, *p* \< 0.001) and significantly more American participants with fewer than 5000 steps/day compared to Japanese participants (18% *vs.* 11%, *p* = 0.02) ([Table 2](#tbl0002){ref-type="table"}).Table 2Physical activity by site.Table 2Pittsburgh (*n* = 265)Kusatsu (*n* = 245)*p*Pedometer steps/day7878 ± 33999055 ± 3797\<0.001 ≥10,000 steps/day56 (21)86 (35)\<0.001 \<5000 steps/day48 (18)27 (11)0.02Leisure MET-h/week15.9 (7.4--30.3)4.0 (0--11.3)\<0.0001 ≥7.5 Leisure MET-h/week196 (74)86 (35)\<0.0001Occupational MET-h/week0 (0--18.5)0 (0--110.8)\<0.0001Total MET-h/week25.1 (11.5--63.0)25.8 (2.1--123.5)0.437Moderate-vigorous leisure PA ≥1 h/week206 (78)76 (31)\<0.0001[^4][^5]

The MAQ past 6-month recall questionnaire was also used to provide information on self-reported PA levels in both cohorts. The top 3 activities in the American cohort were gardening, walking for exercise, and strength training, whereas the top 3 activities in the Japanese cohort were bicycling, walking for exercise, and jogging ([Table 3](#tbl0003){ref-type="table"}).Table 3Common activity ranking in each site (*n* (%)).Table 3Pittsburgh (*n* = 265)Kusatsu (*n* = 245)**Leisure activity**Rank 1Gardening 158 (59.6)Bicycling 66 (26.9)Rank 2Walking 153 (57.7)Walking 59 (24.1)Rank 3Strength training 97 (36.6)Jogging 37 (15.1)Rank 4Jogging 82 (30.9)Calisthenics/ toning 32 (13.1)Rank 5Bicycling 81(30.6)Golf 28 (11.4)Rank 6Golf 56 (21.1)Gardening 25 (10.2)Rank 7Stair master 54 (20.4)Fishing 17 (6.9)Rank 8Swimming 30 (11.3)^a^Swimming 11 (4.5)^a^Rank 8Basketball 30 (11.3)^a^Bowling 11 (4.5)^a^Rank 10Hiking 22 (8.3)Tennis 10 (4.1)**Occupational activity**Rank 1Office worker 195 (73.6)Office worker 128 (52.2)Rank 2Non-office worker 79 (29.8)Non-office worker 117 (47.8)Rank 3Unemployed 11 (4.2)Unemployed 2 (0.8)[^6]

Overall, American participants had significantly higher self-reported median (interquartile range (IQR)) moderate-vigorous leisure activity levels (15.9 (7.4--30.3) MET-h/week *vs.* 4.0 (0--11.3) MET-h/week, *p* \< 0.0001) and were more than twice as likely to self-report 1 h or more of moderate-vigorous leisure PA/week (78% *vs.* 31%). Additionally, the proportion of participants achieving 7.5 or more MET-h/week of leisure activity (equivalent to meeting U.S. and WHO aerobic activity guidelines of 150 min/week of moderate-vigorous intensity PA) was higher in American participants (74% *vs*. 35%, *p* \< 0.0001) ([Table 2](#tbl0002){ref-type="table"}).

Conversely, there were fewer American participants reporting any occupational activity in the American cohort (25.7% *vs.* 44.1 %; data not shown) and the overall distribution of occupational activity levels suggested lower levels for the American participants compared to Japanese participants (median (IQR): 0 (0--18.5) *vs.* 0 (0--110.8) MET-h/week, *p* \< 0.0001). However, when including only those individuals reporting occupational activity, there was no difference in the median (IQR) MET-h/week of work-related activity (American (*n* = 68): 118.8 (80.4--165.7) *vs.* Japanese (*n* = 108): 120.6 (92.3--155.1) MET-h/week, *p* = 0.665.) It should be noted that when leisure and occupational PA were summed and reported as "total PA" there was no significant difference in median total activity values between the cohorts (American: 25.1 (11.5--63.0) *vs.* Japanese: 25.8 (2.1--123.5) MET-h/week, *p* = 0.437). However, when the American cohort was further classified by race/ethnicity, African American participants reported the highest median total, leisure, and occupational PA levels when compared to both American Caucasians and the Japanese cohort (data not shown).

3.3. PA and MetS {#sec0010a}
----------------

Higher counts of pedometer steps were associated with significantly lower odds of having MetS in both populations ([Table 4](#tbl0004){ref-type="table"}). This association remained even after adjustment for age, smoking, and alcohol consumption ([Table 4](#tbl0004){ref-type="table"}). In the fully adjusted model, each 1000 step count/day increase was associated with 10% (OR = 0.90, 95%CI: 0.83--0.98) and 13% (OR = 0.87, 95%CI: 0.80--0.95) lower odds of having MetS among American and Japanese participants, respectively ([Table 4](#tbl0004){ref-type="table"}). For individual MetS components, higher step counts/day were associated with lower odds of having high WC in both populations (American: OR = 0.86, 95%CI: 0.79--0.94; Japanese: OR = 0.88, 95%CI: 0.80--0.95) and high triglycerides in Japanese participants (OR = 0.93, 95%CI: 0.86--0.99). Although no significant associations were observed for high BP, high glucose, and low HDL cholesterol in either cohort ([Table 4](#tbl0004){ref-type="table"}). In the fully adjusted model each 1000 steps count/day increase was also associated with lower odds of obesity, which was significant in the American cohort (OR = 0.89, 95%CI: 0.81--0.97), but not the Japanese cohort (OR = 0.93, 95%CI: 0.86--1.01) ([Table 4](#tbl0004){ref-type="table"}). The results were consistent when pedometer steps were represented as a categorical variable ([Table 5](#tbl0005){ref-type="table"}).Table 4Association of average pedometer steps/day with metabolic syndrome and its components.Table 4Pittsburgh (*n* = 265)Kusatsu (*n* = 245)Model 1Model 2Model 1Model 2βOR (95%CI)βOR (95%CI)βOR (95%CI)βOR (95%CI)Metabolic syndrome ^a^--0.1080.90 (0.83--0.98)\*--0.1060.90 (0.83--0.98)\*--0.14210.87 (0.79--0.95)\*--0.1390.87 (0.80--0.95)\*High waist circumference ^b^--0.1500.86 (0.79--0.94)\*--0.1480.86 (0.79--0.94)\*--0.13320.88 (0.80--0.95)\*--0.1390.87 (0.80--0.95)\*High triglycerides ^c^--0.0740.93 (0.86--1.01)--0.0770.93 (0.86--1.00)--0.07780.93 (0.86--0.99)\*--0.0780.93 (0.86--0.99)\*High blood pressure^d^--0.0380.96 (0.89--1.04)--0.0420.96 (0.90--1.03)--0.05430.95 (0.88--1.01)--0.0600.94 (0.88--1.01)High blood glucose ^e^--0.0360.97 (0.89--1.04)--0.0330.97 (0.89--1.05)--0.03120.97 (0.91--1.04)--0.0300.97 (0.91--1.04)Low HDL cholesterol ^f^--0.0031.00 (0.92--1.09)--0.0060.99 (0.91--1.08)--0.09360.91 (0.80--1.04)--0.0670.94 (0.82--1.07)Obesity ^g^--0.1230.89 (0.81--0.97)\*--0.1210.89 (0.81--0.97)\*--0.06420.94 (0.87--1.01)--0.0710.93 (0.86--1.01)[^7][^8][^9][^10]Table 5Association of categories of pedometer steps with metabolic syndrome and its components.Table 5Pittsburgh (*n* = 265)Kusatsu (*n* = 245)Model 1Model 2Model 1Model 2\<5000 (*n* = 48)5000--9999 (*n* = 161)≥10,000 (*n* = 56)\<5000 (*n* = 48)5000--9999 (*n* = 161)≥10,000 (*n* = 56)\<5000 (*n* = 27)5000--9999 (*n* = 132)≥10,000 (*n* = 86)\<5000 (*n* = 27)5000--9999 (*n* = 132)≥10,000 (*n* = 86)Metabolic syndrome ^a^Ref0.99 (0.20--1.89)0.31 (0.13--0.75)\*Ref0.99 (0.51--1.92)0.32 (0.13--0.78)\*Ref0.32 (0.14--0.75)\*0.20 (0.08--0.50)\*Ref0.32 (0.14--0.77)\*0.19 (0.07--0.49)\*High waist circumference ^b^Ref0.68 (0.35--1.30)0.21 (0.09--0.50)\*Ref0.68 (0.35--1.30)0.22 (0.09--0.52)\*Ref0.58 (0.25--1.35)0.24 (0.09--0.63)\*Ref0.57 (0.24--1.34)0.22 (0.08--0.59)\*High triglycerides ^c^Ref1.40 (0.72--2.74)0.61 (0.26--1.42)Ref1.42 (0.72--2.79)0.60 (0.26--1.41)Ref0.43 (0.19--0.99)\*0.39 (0.16--0.93)\*Ref0.43 (0.19--1.00)0.39 (0.16--0.95)\*High blood pressure^d^Ref0.68 (0.36--1.30)0.52 (0.23--1.14)Ref0.71 (0.37--1.38)0.52 (0.23--1.16)Ref0.51 (0.22--1.18)0.50 (0.21--1.19)Ref0.52 (0.22--1.21)0.47 (0.19--1.14)High blood glucose ^e^Ref0.72 (0.33--1.57)0.51 (0.21--1.25)Ref0.73 (0.33--1.61)0.54 (0.22--1.32)Ref0.91 (0.39--2.10)0.69 (0.29--1.65)Ref0.92 (0.39--2.14)0.68 (0.28--1.64)Low HDL cholesterol^f^Ref1.04 (0.48--2.23)0.56 (0.21--1.53)Ref1.01 (0.46--2.22)0.56 (0.20--1.56)Ref0.32 (0.10--1.05)0.39 (0.11--1.35)Ref0.26 (0.07--0.92)\*0.39 (0.11--1.45)Obesity ^g^Ref0.79 (0.40--1.53)0.32 (0.13--0.79)\*Ref0.79 (0.40--1.56)0.32 (0.13--0.80)\*Ref0.58 (0.25--1.36)0.40 (0.16--1.00)Ref0.56 (0.24--1.31)0.37 (0.15--0.94)[^11][^12][^13][^14]

The relationships between individual components of PA from the MAQ (leisure and occupational) and MetS were also examined. There were no associations between self-reported PA levels and MetS in the Japanese men. However, in the American men higher leisure PA (in MET-h/week) was associated with lower odds of having MetS (OR = 0.98, 95%CI: 0.97--0.99; data not shown) and high WC (OR = 0.98, 95%CI: 0.97--0.99; data not shown). There were also no associations between total PA (leisure and occupational) from the MAQ and MetS or individual components of MetS.

4. Discussion {#sec0011}
=============

In this comparative study of PA and MetS in a cohort both of U.S. and Japanese men, higher levels of average pedometer steps/day were significantly and strongly predictive of lower odds of having MetS (10%--13% for each 1000 steps/day) and lower odds of having high WC (∼12% for each 1000 steps/day) in both cohorts, as well as lower odds of having high triglycerides in the Japanese cohort (∼7% for each 1000 steps/day). Conversely, an examination of the relationship between domain-specific PA and MetS, using a version of the MAQ specifically modified for applicability to both populations, suggested that leisure PA was only related to lower odds of MetS and lower odds of high WC in the U.S. cohort (both ∼2% for each 1 MET-h/week or 20 min/week of moderate-intensity PA), but not the Japanese cohort. Further examination of the MAQ data to include both leisure and occupational PA did not show a contribution of occupational PA as measured by the MAQ. This finding suggests that when cross-instrument-measured bias in PA reporting is eliminated from the results, total ambulatory movement in both cohorts was more related to MetS and individual MetS components when compared to self-reported domain-specific PA.

A number of previous studies have shown an association between higher step counts and lower odds of MetS in American or Japanese populations.[@bib0034], [@bib0035], [@bib0036], [@bib0037], [@bib0038] However, due to differences in study populations and measurement methods for PA, it is difficult to know whether these findings were "real" or whether they were an artifact caused by differences in how PA data were collected and reported. For example, inclusion criteria and wear time criteria varied by study (e.g., measurement of step counts ranged from only 1 day to 3 consecutive days to 7 consecutive days).

When PA was examined as average total pedometer step counts per day, our study showed that the associations between PA and MetS are very similar for middle-aged men in both countries, using the exact same methods. The study inclusion criteria were also the same in both countries, resulting in a narrow age range of participants, thus reducing confounding by age. Furthermore, compared to previous studies that only used larger cut point categories for reporting step counts, our study showed that even increments of 1000 steps/day were associated with important reductions in the odds of having MetS in both countries, which suggests that step count-based PA intervention efforts to decrease MetS could be impactful in both the United States and Japan.

Our findings suggest that average total step counts/day may be important to the prevalence of MetS in both Japanese and American men. Pedometers are able to capture activities that are difficult to capture via questionnaire (hard to recall), such as unplanned activities that may be of shorter duration and/or lower intensity (such as light-intensity activity). In relation to this, previous studies have shown that light PA,[@bib0039] and even short bouts of PA such as total PA lasting less than 3 min and moderate to vigorous PA lasting less than 32 s[@bib0040] are associated with lower prevalence of MetS or individual MetS components. Accumulation of light PA and short bouts of PA that could be captured with pedometer steps but not with the MAQ may have resulted in favorable hormonal profiles in our study population. Because questionnaires are not as good at capturing total ambulatory movement (including unplanned and low-intensity PA),[@bib0010]^,^[@bib0013] these findings may help to explain why previously published studies largely based on questionnaire data have shown inconsistent findings across countries for the relationship between PA and MetS.[@bib0041], [@bib0042], [@bib0043], [@bib0044]

Our results suggested that higher levels of leisure PA, collected via the MAQ, were associated with lower odds of MetS in the cohort of American men but not Japanese men. This finding, which showed a smaller effect size than that of total pedometer steps per day, suggests that leisure PA likely contributes to some, but not all, of the effect of total movement (from all intensity levels and domains) on MetS and WC in the American cohort but does not significantly contribute the effect in the Japanese cohort. The fact that there was no significant effect of leisure PA in the Japanese cohort may be due to the much lower reported leisure PA levels among Japanese participants (i.e., leisure PA, as recorded by the MAQ, is not how they accumulated step counts).

This study also illustrates the important differences in patterns of PA between the American and Japanese cohorts, which may explain the inconsistent findings in previous studies regarding the relationship between PA levels and MetS. Depending on the methods of PA assessment, comparison of PA levels have resulted in substantially different findings.[@bib0005], [@bib0006], [@bib0007], [@bib0008] One study suggested that PA was similar between 2 countries when combined self-reported work and leisure PA was measured.[@bib0015] However, other studies have suggested that Americans have higher self-reported moderate to vigorous leisure PA[@bib0008] and lower self-reported occupational PA[@bib0017] compared to the Japanese. Our study, which confirmed these differences in a standardized setting, highlights the importance of assessing various aspects of PA in cross-country comparisons when the sources of PA differ across populations. Furthermore, our findings suggest that leisure PA levels were more important toward MetS prevalence in the U.S. cohort compared to the Japanese cohort, where the effect was not significant. In our study, the use of the MAQ, which was originally designed to be modified for use across cultures, was effective at capturing these differences but likely did not capture all components of PA important to MetS prevalence in both cohorts. This suggests the need for methods that capture aspects of PA, including light-intensity PA and unplanned activities, that are difficult to assess with questionnaires. However, it should be noted that questionnaires may be useful as a complementary tool to identify the specific components of PA that contribute to the relationship between overall PA levels and MetS.

Our study has several limitations. First, as with most previous studies, the cross-sectional design does not allow us to determine if the relationship between PA and MetS in causal.[@bib0045] Second, although we used representative samples of populations, our population was limited to middle-aged men at participating sites. Therefore, it is unknown if the results are generalizable to wider Japanese and American populations, which include men in other cities, younger adults, and women. Third, although we adjusted for alcohol use, we did not adjust for other dietary factors. It is possible that some of the association between PA and MetS may be mediated by dietary factors. Finally, there is no gold standard measure for PA that will capture complete information on PA that includes a valid measure of total ambulatory movement and distinguishes the types of activities performed. Therefore, it was necessary to administer both an objective and subjective measure of PA.

However, there are also various strengths to our study. Ours is the first study to compare PA levels in the United States and Japan using both subjective and objective measurement tools. Our study is also the first to assess the association of PA and MetS in the 2 countries simultaneously using standardized methods for outcome collection and processing of PA data. The use of both subjective and objective measures to assess PA enabled us to investigate the associations between MetS and more components of PA. Unlike some studies that measured only 1 day or a few days of pedometer steps, our study used validated methods that only included participants with pedometer steps data for 3 or more of the 7 consecutive days. Also, compared to the age range in previous studies, the age range of our participants was small (13 years), which resulted in less confounding by age.

5. Conclusion {#sec0012}
=============

These results showed that average total step counts/day had a strong protective effect on MetS in both the U.S. and Japanese cohorts of middle-aged men, despite differences in other risk factors across the populations. The effect was stronger than any specific component of PA or the combined "total" PA reported through the questionnaire. This suggests that components of PA, such as light-intensity PA and unplanned PA, which can be captured by a pedometer but are difficult to accurately capture with questionnaires, are important in reducing MetS development in both cohorts. Studies that seek to examine the importance of PA levels to MetS prevalence and incidence within and across countries may want to consider using an objective measurement method that can capture total ambulation or total movement across all domains of activity as a way to ensure that all relevant domains of PA are captured. Questionnaires may additionally be valuable to illuminate the contribution of specific components of PA that are important to MetS prevention in each cohort.
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[^1]: Notes: The bolding was used to highlight metabolic syndrome, which is the primary outcome of interest. Data are mean ± SD or *n* (%).

[^2]: ^a^ BMI ≥30 kg/m^2^ in American men and BMI ≥25 kg/m^2^ in Japanese men; ^b^ Analyzed among those without medication use; ^c^ ≥3 of 5 components; ^d^ ≥102 cm in American men and ≥90 cm in Japanese men; ^e^ Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg or on medication; ^f^ Fasting glucose ≥100 mg/dL or on medication; ^g^ Triglycerides ≥150 mg/dL or on medication; ^h^ HDL cholesterol \<40 mg/dL or on medication.

[^3]: Abbreviations: BMI = body mass index; HDL = high density lipoprotein; LDL = low density lipoprotein.

[^4]: Note: Values are mean ± SD, *n* (%), or median (IQR).

[^5]: Abbreviations: IQR = interquartile range; MET = metabolic equivalent task; PA = physical activity

[^6]: ^a^ Activities with tied ranking.

[^7]: Note: Betas and ORs are expressed per 1000 pedometer steps/day. Model 1: unadjusted; Model 2: Model 1 + age, smoking, and alcohol.

[^8]: ^a^ ≥3 of 5 components; ^b^ ≥102 cm in American men and ≥90 cm in Japanese men; ^c^ Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg or on medication; ^d^ Triglycerides ≥150 mg/dL or on medication; ^e^ HDL-cholesterol \<40 mg/dL or on medication; ^f^ Fasting glucose ≥100 mg/dL or on medication; ^g^ BMI ≥30 kg/m^2^ in American men and BMI ≥25 kg/m^2^ in Japanese men.

[^9]: \* *p* \< 0.05.

[^10]: Abbreviations: BMI = body mass index; CI = confidential interval; HDL = high density lipoprotein; LDL = low density lipoprotein; OR = odds ratio.

[^11]: Notes: Model 1: unadjusted; Model 2: Model 1 + age, smoking, and alcohol.

[^12]: ^a^ ≥3 of 5 components; ^b^ ≥102 cm in American men and ≥90 cm in Japanese men; ^c^ Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg or on medication; ^d^ Triglycerides ≥150 mg/dL or on medication; ^e^ HDL-cholesterol \<40 mg/dL or on medication; ^f^ Fasting glucose ≥100 mg/dL or on medication; ^g^ BMI ≥30 kg/m^2^ in American men and BMI ≥25 kg/m^2^ in Japanese men.

[^13]: \* *p* \< 0.05.

[^14]: Abbreviations: BMI = body mass index; HDL = high density lipoprotein; LDL = low density lipoprotein; Ref = reference group.
